ストックスクリーナーアプリを入手
80.80
2.25%
1.78
アフターアワーズ：
77.85
-2.95
-3.65%
前日終値:
$79.02
開ける：
$78.26
24時間の取引高:
1.04M
Relative Volume:
1.00
時価総額：
$14.01B
収益：
$8.31B
当期純損益:
$379.00M
株価収益率:
37.41
EPS:
2.16
ネットキャッシュフロー:
$385.00M
1週間 パフォーマンス:
+0.89%
1か月 パフォーマンス:
-5.42%
6か月 パフォーマンス:
+2.93%
1年 パフォーマンス:
+20.38%
1日の値動き範囲:
$78.18
$81.34
1週間の範囲:
$78.18
$81.34
52週間の値動き範囲:
$60.70
$88.20
Solventum Corp Stock (SOLV) Company Profile
SOLV を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
SOLV
Solventum Corp
|
80.80 | 13.71B | 8.31B | 379.00M | 385.00M | 2.16 |
|
ISRG
Intuitive Surgical Inc
|
566.38 | 199.22B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
198.96 | 55.54B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
80.65 | 38.12B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
245.36 | 35.73B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
MDLN
Medline Inc
|
39.00 | 31.97B | 27.43B | 1.27B | 1.01B | 1.5829 |
Solventum Corp Stock (SOLV) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-12-02 | アップグレード | BTIG Research | Neutral → Buy |
| 2025-10-01 | 開始されました | UBS | Neutral |
| 2025-09-11 | 開始されました | Jefferies | Hold |
| 2025-07-15 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2025-07-01 | アップグレード | Argus | Hold → Buy |
| 2025-06-06 | 開始されました | KeyBanc Capital Markets | Sector Weight |
| 2025-05-19 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2024-12-04 | 開始されました | Mizuho | Neutral |
| 2024-10-08 | 開始されました | Stifel | Buy |
| 2024-10-07 | 開始されました | Piper Sandler | Neutral |
| 2024-09-26 | 開始されました | Wolfe Research | Peer Perform |
| 2024-09-05 | 開始されました | BTIG Research | Neutral |
| 2024-06-24 | 開始されました | Argus | Hold |
| 2024-05-30 | 開始されました | Goldman | Sell |
| 2024-05-10 | 開始されました | BofA Securities | Neutral |
| 2024-04-10 | 開始されました | Morgan Stanley | Equal-Weight |
| 2024-04-08 | 開始されました | Wells Fargo | Equal Weight |
| 2024-04-02 | 開始されました | Edward Jones | Hold |
すべてを表示
Solventum Corp (SOLV) 最新ニュース
Solventum Advances Orthodontic Treatment by Helping Shape Modern Orthodontics - Digital Journal
Bioprocess Filtration Global Markets Report 2025-2030, Profiles of Leading PlayersDanaher, Merck, Sartorius, Solventum, and RepligenResearchAndMarkets.com - FinancialContent
Solventum Corp. stock falls Wednesday, underperforms market - MarketWatch
Solventum to Acquire Acera Surgical in $725 Mn Deal to Boost Regenerative Wound-Care Portfolio - Digital Health News
Key sale, acquisition helped 3M spinoff, Solventum, turn around in 2025 - Star Tribune
Are Medical Stocks Lagging Solventum Corporation (SOLV) This Year? - Yahoo Finance
Harbor Capital Advisors Inc. Has $1.31 Million Stake in Solventum Corporation $SOLV - MarketBeat
Solventum Corporation (NYSE:SOLV) Given Consensus Rating of "Hold" by Analysts - MarketBeat
SOLV Acquires Acera Surgical to Expand Advanced Wound Care Portfolio - sharewise.com
Strong Tower Advisory Services Buys 16,851 Shares of Solventum Corporation $SOLV - MarketBeat
Solventum Completes Acquisition of Acera Surgical - The Malaysian Reserve
Solventum completes acquisition of Acera Surgical for $725 million By Investing.com - Investing.com Nigeria
Solventum Closes Acquisition of Acera Surgical - marketscreener.com
Solventum completes Acera Surgical acquisition - MassDevice
Solventum completes acquisition of Acera Surgical for $725 million - Investing.com India
Solventum is the top performing healthcare supplies stock YTD - MSN
Solventum is the top performing healthcare supplies stock YTD (SOLV:NYSE) - Seeking Alpha
Is Solventum stock outperforming the Nasdaq? - MSN
How Investors Are Reacting To Solventum (SOLV) Expert Guidance Expanding Use Of Prevena ciNPT Dressings - simplywall.st
Wedge Capital Management L L P NC Sells 64,461 Shares of Solventum Corporation $SOLV - MarketBeat
Will Expert Backing for ciNPT Prevena Dressings Redefine Solventum's (SOLV) Advanced Wound Care Edge? - Yahoo Finance
Why retail investors pile into Solventum Corporation stock2025 Top Decliners & Stepwise Swing Trade Plans - Улправда
Is Solventum Stock Underperforming the S&P 500? - MSN
Solventum (SOLV): Assessing Valuation After New Clinical Guidance Expands Prevena Therapy’s Surgical Use - simplywall.st
Argus Research Adjusts Solventum Price Target to $100 From $90, Maintains Buy Rating - marketscreener.com
Assenagon Asset Management S.A. Boosts Position in Solventum Corporation $SOLV - MarketBeat
Global Expert Panel Publishes New Recommendations on Advanced Use of Closed Incision Negative Pressure Therapy - Finviz
New surgery guidelines expand use of vacuum dressings to protect incisions - Stock Titan
Piper Sandler names Solventum stock its 2026 top idea, maintains $98 target - Investing.com Nigeria
Solventum Corporation reflects on transformative year - MSN
Solventum Earns Diamond Level HIRC Resiliency Badge, Demonstrating Best-In-Class Supply Chain Strength - Finviz
Solventum Corp. stock falls Tuesday, underperforms market - MarketWatch
Solventum earns diamond level supply chain certification for healthcare By Investing.com - Investing.com Australia
Solventum earns diamond level supply chain certification for healthcare - Investing.com
3M at a Crossroads: Strategic Moves and Persistent Headwinds - AD HOC NEWS
Solventum Corporation Reflects on Transformative Year - TipRanks
Wells Fargo Adjusts Price Target on Solventum to $86 From $72, Maintains Equalweight Rating - marketscreener.com
Solventum Corp Reflects on Year of Growth and Transformation - TradingView — Track All Markets
Is Solventum Stock Outperforming the Nasdaq? - Yahoo Finance
Solventum Corp. stock falls Monday, underperforms market - MarketWatch
Solventum Corp (SOLV) 財務データ
収益
当期純利益
現金流量
EPS
Solventum Corp (SOLV) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| 3M CO | 10% Owner |
Aug 15 '25 |
Sale |
73.45 |
8,800,000 |
646,360,000 |
25,569,190 |
| COX CARRIE SMITH | Director |
May 13 '25 |
Option Exercise |
0.00 |
5,148 |
0 |
5,148 |
| Hanson Bryan C | Chief Executive Officer |
May 13 '25 |
Option Exercise |
0.00 |
34,315 |
0 |
75,108 |
| Harris Bernard A Jr | Director |
May 13 '25 |
Option Exercise |
0.00 |
3,564 |
0 |
3,564 |
| Edwards Shirley Ann | Director |
May 13 '25 |
Option Exercise |
0.00 |
3,564 |
0 |
3,564 |
| Wilcox Mary T | Chief Accounting Officer |
May 13 '25 |
Option Exercise |
0.00 |
2,375 |
0 |
2,375 |
| DeVore Susan D. | Director |
May 13 '25 |
Option Exercise |
0.00 |
3,564 |
0 |
3,564 |
| ALBAN CARLOS | Director |
May 13 '25 |
Option Exercise |
0.00 |
3,564 |
0 |
3,564 |
| Harrington Paul S | Chief Supply Chain Officer |
May 13 '25 |
Option Exercise |
0.00 |
3,959 |
0 |
11,220 |
| Wendell Amy McBride | Director |
May 13 '25 |
Option Exercise |
0.00 |
3,564 |
0 |
3,564 |
2.01%
3.99%
大文字化:
|
ボリューム (24 時間):